How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Peptide Synthesis Instruments Market
- By Synthesis Technology: Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), Microwave-Assisted Peptide Synthesis, Automated Peptide Synthesizers, Manual Peptide Synthesizers
- By Instrument Type: Automated Peptide Synthesizers, Semi-Automated Peptide Synthesizers, Manual Peptide Synthesizers, Peptide Synthesizer Accessories, Peptide Synthesizer Consumables
- By Application: Pharmaceutical Research, Biotechnology Research, Academic Research, Industrial Peptide Production, Diagnostic Peptide Synthesis
- By End User: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs), Diagnostic Laboratories, Industrial Peptide Manufacturers
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Solid Phase Peptide Synthesis (SPPS) leads By Synthesis Technology at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 13 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 277 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.170 →
- 11 Company Profiles 13 players: SWOT & benchmarking p.178 →
Full report · locked preview
Everything inside the Peptide Synthesis Instruments Market report
A complete, evidence-based study - 11 chapters and 116 sections covering market size, segmentation across 4 axes, regional analysis and 13 company profiles, forecast to 2033.
Segmentation covered
Synthesis Technology 5
Instrument Type 5
Application 5
End User 5
Companies profiled
Thermo Fisher Scientific
CEM Corporation
Biotage AB
Aapptec
Gyros Protein Technologies
Intavis Bioanalytical Instruments AG
CSBio
Peptide Synthetics Ltd
Shimadzu Corporation
Protein Technologies Inc.
Peptide International Inc.
Bachem AG
+1 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
13 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →CEM Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Biotage AB
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Aapptec
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Gyros Protein Technologies
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Intavis Bioanalytical Instruments AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →CSBio
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Peptide Synthetics Ltd
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Shimadzu Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Protein Technologies Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Peptide International Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Bachem AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →AAPPTec
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,960M by 2033 · 4.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Solid Phase Peptide Synthesis (SPPS)30.9
- Liquid Phase Peptide Synthesis (LPPS)13.2
- Microwave-Assisted Peptide Synthesis10.3
- Automated Peptide Synthesizers24.3
- Manual Peptide Synthesizers21.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$686.0M → $945.5M · 4.1%
Europe$478.1M → $607.1M · 3.0%
Asia Pacific$436.5M → $650.1M · 5.1%
Latin America$270.2M → $349.1M · 3.3%
Middle East and Africa$207.9M → $327.5M · 5.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.472026
4.482027
4.502028
4.502029
4.512030
4.542031
4.552032
4.552033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific9.4
- CEM Corporation24.2
- Biotage AB10.4
- Aapptec6.6
- Gyros Protein Technologies11.7
- Intavis Bioanalytical Instruments AG9.7
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Synthesis Technology26.2%
Instrument Type20.9%
Application15.1%
End User37.8%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.8
- Europe21.1
- Asia Pacific22.6
- Latin America12.1
- Middle East and Africa11.4
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 97 | 97 | 82 | 98 | 81 | 77 | 89 |
| CEM Corporation | 91 | 77 | 81 | 83 | 86 | 76 | 82 |
| Biotage AB | 86 | 81 | 80 | 87 | 69 | 76 | 80 |
| Aapptec | 71 | 76 | 71 | 58 | 77 | 78 | 72 |
| Gyros Protein Technologies | 67 | 54 | 62 | 67 | 52 | 67 | 62 |
| Intavis Bioanalytical Instruments AG | 70 | 64 | 67 | 58 | 54 | 54 | 61 |
| CSBio | 40 | 49 | 46 | 50 | 41 | 40 | 44 |
| Peptide Synthetics Ltd | 43 | 60 | 60 | 57 | 51 | 40 | 52 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- CEM Corporation
- Biotage AB
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ✓ | ✓ | ✓ | ✓ | ✓ | ◐ |
| CEM Corporation | ✓ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Biotage AB | ◐ | ✓ | ✓ | ✓ | ◐ | ◐ |
| Aapptec | ✓ | ◐ | ◐ | − | ◐ | ✓ |
| Gyros Protein Technologies | ✓ | − | − | ◐ | ◐ | ◐ |
| Intavis Bioanalytical Instruments AG | ◐ | ✓ | − | − | − | − |
| CSBio | − | − | − | − | − | ◐ |
| Peptide Synthetics Ltd | ◐ | ◐ | ◐ | ◐ | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific89
2CEM Corporation82
3Biotage AB80
4Aapptec72
5Gyros Protein Technologies62
6Intavis Bioanalytical Instruments AG61
7Peptide Synthetics Ltd52
8CSBio44
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Thermo Fisher ScientificCEM CorporationBiotage AB
Challenger1
Strong scale, closing on the leaders.
Aapptec
Contender2
Focused players with pockets of strength.
Gyros Protein TechnologiesIntavis Bioanalytical Instruments AG
Niche2
Specialists in a single segment or region.
CSBioPeptide Synthetics Ltd
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Synthesis Technology in North America, then scale across Peptide Synthesis Instruments Market — a $506M beachhead inside a $8.84B market.
Beachhead (SOM)$506Mobtainable near-term
Serviceable (SAM)$3.07Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Solid Phase Peptide Synthesis (SPPS)
Best fit — highest urgency & budget in Synthesis Technology.
Economic buyer79 fit
Liquid Phase Peptide Synthesis (LPPS)
Strong fit — clear ROI and a fast path to value.
End user69 fit
Microwave-Assisted Peptide Synthesis
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Synthesis Technology in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Instrument Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel30%
Digital / self-serve17%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Synthesis Technology leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Peptide Synthesis Instruments Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified25%
Evaluation14%
Closed-won6%
$12.4KCAC
$43KLTV
3.5:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Peptide Synthesis Instruments Market is a durable-growth opportunity — $4.90B by 2033, compounding at 9.7%.
TAM · 2025$2.35Btoday
TAM · 2033$4.90Bforecast
CAGR9.7%2027–2033
Cumulative$31.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.90BTotal addressable market
SAM$2.05BServiceable available market
SOM$410MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.7% CAGR
Demand compounds through 2033, outpacing GDP across Synthesis Technology.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Synthesis Technology moving from early to mainstream — durable secular demand.
Consolidation upside
13+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.90BLarge & growingTAM by 2033 at 9.7% CAGR
$2.05BServiceable nowreachable with today’s model
$410MBeachhead winobtainable near-term share
13+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.82BBear6.3% CAGR
$4.90BBase9.7% CAGR
$6.27BBull12.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Instrument Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Peptide Synthesis Instruments Market — a $8.59B market by 2033. Plan: grow share from 9.9% to 16.0%.
Market size · 2033$8.59Btotal addressable
Market CAGR6.1%2027–2033
Target share16.0%from 9.9% today
Revenue ambition$1.37Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.9% | 16.0% | On track |
| Revenue | $803M | $1.37B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Ahead |
| Gross margin | 30.9% | 44.3% | At risk |
| Customer retention | 84.7% | 95.1% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Synthesis Technology
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Instrument Type capability
A defensible second engine — invest in Instrument Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Synthesis Technology share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Instrument Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $160M capacity & capability investment
- Greenlight bolt-on M&A in Instrument Type
- Authorise North America expansion plan
- Fund R&D program for Synthesis Technology leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossAt risk
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Peptide Synthesis Instruments Market conversation — a $819M market you can size, segment and defend in minutes.
Market size · 2033$819Mtotal opportunity
Growth4.2%CAGR to 2033
Addressable buyers1,061+accounts in scope
Typical ROI5.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Synthesis Technology
Goal Grow share in Synthesis Technology
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.3×return on cost, year one
< 3 mopayback period
$88K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
13+players profiled in this market
Coverage includes
Thermo Fisher ScientificCEM CorporationBiotage ABAapptecGyros Protein TechnologiesIntavis Bioanalytical Instruments AGCSBioPeptide Synthetics Ltd+5 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Peptide Synthesis Instruments Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Peptide Synthesis Instruments Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Peptide Synthesis CMO Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportPeptides Market
Peptides Market is valued at USD 28.9 Billion in 2025 and is expected to reach USD 53.5 Billion…
$28.9B market · 2025 base year
View reportPeptides Extraction Kits Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportPeptide Screening Service Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportPeptides and Heparin Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportPeptide Purification System Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportPeptide Microarray Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportPeptide Microarray Assay Service Market
Market size, share, segmentation and regional forecast.
$677M market · 2025 base year
View reportPeptide Library Screening Services Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportPeptide Health Products Market
Peptide Health Products Market is valued at USD 11.5 Billion in 2025 and is expected to reach U…
$11.5B market · 2025 base year
View reportPeptide-Drug Conjugates Market
Market size, share, segmentation and regional forecast.
$539M market · 2025 base year
View reportPeptide Coupling Reagent Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.